• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病的睡眠与非运动症状。

Sleep and non-motor symptoms in Parkinson's disease.

机构信息

Department of Neurology, University Hospital 'Carl Gustav Carus', University of Technology Dresden, Fetscherstrasse 74, 01307, Dresden, Germany.

出版信息

J Neural Transm (Vienna). 2013 Apr;120(4):565-9. doi: 10.1007/s00702-013-0966-4. Epub 2013 Jan 22.

DOI:10.1007/s00702-013-0966-4
PMID:23338671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3611039/
Abstract

Beyond the cardinal motor symptoms, bradykinesia, rigidity, tremor and postural instability, defining the diagnosis of Parkinson's disease, there is a big spectrum of non-motor features that patients may suffer from and that may reduce their quality of life. Non-motor symptoms are not only frequent but also often under-reported by patients and caregivers. As they are frequently under-recognized by clinicians, they remain consequently under-treated. This review wants to give a short overview of the importance of non-motor symptoms on patients' quality of life and helpful assessment tools that might facilitate recognition of non-motor features during clinical setting. Given the wide range of non-motor symptoms in Parkinson's disease, we concentrate on common issues such as depression and sleep disorders like sleep-onset insomnia or sleep maintenance insomnia and restless legs syndrome. Thereby, we present some recent studies that have investigated the efficacy of dopaminergic drugs, especially dopamine agonists, revealing possible treatment strategies and thus improving disease management.

摘要

除了帕金森病的主要运动症状,如运动迟缓、肌肉僵直、震颤和姿势不稳等,用于定义帕金森病的诊断外,还有一大类非运动症状可能会使患者遭受痛苦,并降低其生活质量。非运动症状不仅很常见,而且常常被患者和护理人员漏报。由于临床医生往往对此认识不足,这些症状的治疗也因此不足。本综述旨在简要概述非运动症状对患者生活质量的重要性,以及有助于在临床环境中识别非运动特征的有用评估工具。鉴于帕金森病中非运动症状的范围很广,我们集中讨论了常见问题,如抑郁和睡眠障碍,如入睡困难或睡眠维持困难和不宁腿综合征。因此,我们介绍了一些最近的研究,这些研究调查了多巴胺能药物,特别是多巴胺激动剂的疗效,揭示了可能的治疗策略,从而改善了疾病管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d8/3611039/654ec4ae3a37/702_2013_966_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d8/3611039/654ec4ae3a37/702_2013_966_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09d8/3611039/654ec4ae3a37/702_2013_966_Fig1_HTML.jpg

相似文献

1
Sleep and non-motor symptoms in Parkinson's disease.帕金森病的睡眠与非运动症状。
J Neural Transm (Vienna). 2013 Apr;120(4):565-9. doi: 10.1007/s00702-013-0966-4. Epub 2013 Jan 22.
2
An overview of the effects of levodopa and dopaminergic agonists on sleep disorders in Parkinson's disease.左旋多巴和多巴胺激动剂对帕金森病睡眠障碍影响的概述。
J Clin Sleep Med. 2023 Jun 1;19(6):1133-1144. doi: 10.5664/jcsm.10450.
3
Sleep Issues in Parkinson's Disease and Their Management.帕金森病中的睡眠问题及其管理。
Neurotherapeutics. 2020 Oct;17(4):1480-1494. doi: 10.1007/s13311-020-00938-y. Epub 2020 Oct 7.
4
Beyond tremor and rigidity: non-motor features of Parkinson's disease.除了震颤和僵硬:帕金森病的非运动特征。
J Neural Transm (Vienna). 2009 Nov;116(11):1483-92. doi: 10.1007/s00702-009-0274-1. Epub 2009 Aug 14.
5
[Sleep disturbances in Parkinson's disease].[帕金森病中的睡眠障碍]
Neurol Neurochir Pol. 2005 Sep-Oct;39(5):380-8.
6
Treatment strategies for nonmotor manifestations of Parkinson's disease.帕金森病非运动症状的治疗策略。
Expert Opin Pharmacother. 2009 Apr;10(5):773-84. doi: 10.1517/14656560902811605.
7
Frequency of non-motor symptoms and their impact on the quality of life in patients with Parkinson's disease: a prospective descriptive case series.帕金森病患者非运动症状的发生频率及其对生活质量的影响:一项前瞻性描述性病例系列研究。
Psychogeriatrics. 2020 Mar;20(2):206-211. doi: 10.1111/psyg.12489. Epub 2019 Nov 28.
8
Non-motor symptoms in Parkinson's disease.帕金森病的非运动症状
J Neurol. 2009 Aug;256 Suppl 3:293-8. doi: 10.1007/s00415-009-5240-1.
9
Mood and sleep in Parkinson's disease.帕金森病中的情绪与睡眠
J Clin Psychiatry. 2006 Jun;67(6):958-63. doi: 10.4088/jcp.v67n0613.
10
Spectrum of Non-Motor Symptoms in Parkinson's Disease.帕金森病的非运动症状谱
Cureus. 2021 Feb 11;13(2):e13275. doi: 10.7759/cureus.13275.

引用本文的文献

1
Revolutionizing our understanding of Parkinson's disease: Dr. Heinz Reichmann's pioneering research and future research direction.颠覆帕金森病认知的革命:海因茨·赖希曼博士的开拓性研究与未来研究方向。
J Neural Transm (Vienna). 2024 Dec;131(12):1367-1387. doi: 10.1007/s00702-024-02812-z. Epub 2024 Aug 7.
2
Dopamine transporter binding in the brain is linked to irritable bowel syndrome in Parkinson's disease.大脑中的多巴胺转运体结合与帕金森病中的肠易激综合征有关。
Brain Behav. 2023 Jul;13(7):e3097. doi: 10.1002/brb3.3097. Epub 2023 May 30.
3
Effects of safinamide on pain in patients with fluctuating Parkinson's disease.

本文引用的文献

1
European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society.欧洲不安腿综合征管理指南:欧洲神经病学学会联合会、欧洲神经科学学会和欧洲睡眠研究学会联合工作组报告。
Eur J Neurol. 2012 Nov;19(11):1385-96. doi: 10.1111/j.1468-1331.2012.03853.x. Epub 2012 Sep 3.
2
Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER).罗替戈汀对帕金森病患者清晨运动功能和睡眠的影响:一项双盲、随机、安慰剂对照研究(RECOVER)。
Mov Disord. 2011 Jan;26(1):90-9. doi: 10.1002/mds.23441. Epub 2010 Nov 18.
3
在帕金森病波动患者中,司来吉兰对疼痛的影响。
Brain Behav. 2021 Oct;11(10):e2336. doi: 10.1002/brb3.2336. Epub 2021 Sep 3.
4
Pathophysiological Changes in the Enteric Nervous System of Rotenone-Exposed Mice as Early Radiological Markers for Parkinson's Disease.鱼藤酮暴露小鼠肠道神经系统的病理生理变化作为帕金森病的早期影像学标志物
Front Neurol. 2021 Mar 22;12:642604. doi: 10.3389/fneur.2021.642604. eCollection 2021.
5
Environmental neurotoxicant-induced dopaminergic neurodegeneration: a potential link to impaired neuroinflammatory mechanisms.环境神经毒性诱导的多巴胺能神经退行性变:与神经炎症机制受损的潜在关联。
Pharmacol Ther. 2019 May;197:61-82. doi: 10.1016/j.pharmthera.2019.01.001. Epub 2019 Jan 22.
6
Sleep Attacks in Patients With Parkinson's Disease on Dopaminergic Medications: A Systematic Review.帕金森病患者使用多巴胺能药物时的睡眠发作:一项系统评价
Mov Disord Clin Pract. 2014 Sep 1;1(4):307-316. doi: 10.1002/mdc3.12063. eCollection 2014 Dec.
7
Oxidative Stress in Parkinson's Disease: A Systematic Review and Meta-Analysis.帕金森病中的氧化应激:系统评价与荟萃分析
Front Mol Neurosci. 2018 Jul 5;11:236. doi: 10.3389/fnmol.2018.00236. eCollection 2018.
8
Tamoxifen usage correlates with increased risk of Parkinson's disease in older women with breast cancer: a case-control study in Taiwan.他莫昔芬的使用与老年乳腺癌女性患帕金森病的风险增加相关:台湾的一项病例对照研究。
Eur J Clin Pharmacol. 2018 Jan;74(1):99-107. doi: 10.1007/s00228-017-2341-0. Epub 2017 Oct 1.
9
Identification of key genes and pathways in Parkinson's disease through integrated analysis.通过综合分析鉴定帕金森病的关键基因和通路。
Mol Med Rep. 2017 Oct;16(4):3769-3776. doi: 10.3892/mmr.2017.7112. Epub 2017 Jul 31.
10
Herpes zoster correlates with increased risk of Parkinson's disease in older people: A population-based cohort study in Taiwan.带状疱疹与老年人患帕金森病的风险增加相关:一项基于台湾人群的队列研究。
Medicine (Baltimore). 2017 Feb;96(7):e6075. doi: 10.1097/MD.0000000000006075.
Parkinson's disease sleep scale--validation of the revised version PDSS-2.
帕金森病睡眠量表-修订版 PDSS-2 的验证。
Mov Disord. 2011 Mar;26(4):644-52. doi: 10.1002/mds.23476. Epub 2011 Feb 10.
4
Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson's disease.罗替高汀透皮贴剂治疗帕金森病患者晨僵及睡眠障碍
J Neural Transm (Vienna). 2010 Dec;117(12):1395-9. doi: 10.1007/s00702-010-0506-4. Epub 2010 Nov 16.
5
Measurement of patient-centered outcomes in Parkinson's disease: what do patients really want from their treatment?帕金森病患者中心结局的测量:患者对治疗的真正需求是什么?
Parkinsonism Relat Disord. 2011 Feb;17(2):89-94. doi: 10.1016/j.parkreldis.2010.09.005. Epub 2010 Oct 16.
6
Parkinson's disease symptoms: the patient's perspective.帕金森病症状:患者的视角。
Mov Disord. 2010 Aug 15;25(11):1646-51. doi: 10.1002/mds.23135.
7
A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder.褪黑素治疗 REM 睡眠行为障碍的双盲、安慰剂对照、两部分研究。
J Sleep Res. 2010 Dec;19(4):591-6. doi: 10.1111/j.1365-2869.2010.00848.x.
8
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.普拉克索治疗帕金森病患者抑郁症状的随机、双盲、安慰剂对照试验。
Lancet Neurol. 2010 Jun;9(6):573-80. doi: 10.1016/S1474-4422(10)70106-X. Epub 2010 May 7.
9
The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire.帕金森病非运动症状向医护人员隐瞒情况:使用非运动症状问卷的国际研究。
Mov Disord. 2010 Apr 30;25(6):704-9. doi: 10.1002/mds.22868.
10
Best practice guide for the treatment of REM sleep behavior disorder (RBD).快速眼动睡眠行为障碍(RBD)治疗的最佳实践指南。
J Clin Sleep Med. 2010 Feb 15;6(1):85-95.